On Friday, Bluebird bio Inc (NASDAQ: BLUE) opened lower -3.79% from the last session, before settling in for the closing price of $0.50. Price fluctuations for BLUE have ranged from $0.45 to $5.53 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 120.02%. Company’s average yearly earnings per share was noted 20.29% at the time writing. With a float of $192.36 million, this company’s outstanding shares have now reached $192.77 million.
Let’s determine the extent of company efficiency that accounts for 375 employees. In terms of profitability, gross margin is -37.34%, operating margin of -609.26%, and the pretax margin is -567.34%.
Bluebird bio Inc (BLUE) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Bluebird bio Inc is 0.80%, while institutional ownership is 42.46%. The most recent insider transaction that took place on Sep 30 ’24, was worth 529. In this transaction an insider of this company sold 1,006 shares at a rate of $0.53, taking the stock ownership to the 170,000 shares. Before that another transaction happened on Sep 30 ’24, when Company’s President and CEO sold 34,780 for $0.53, making the entire transaction worth $18,270. This insider now owns 375,218 shares in total.
Bluebird bio Inc (BLUE) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -0.66 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.67) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.29 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 20.29% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 45.80% during the next five years compared to 28.98% growth over the previous five years of trading.
Bluebird bio Inc (NASDAQ: BLUE) Trading Performance Indicators
Check out the current performance indicators for Bluebird bio Inc (BLUE). In the past quarter, the stock posted a quick ratio of 0.57. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.14, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -0.62 in one year’s time.
Technical Analysis of Bluebird bio Inc (BLUE)
Looking closely at Bluebird bio Inc (NASDAQ: BLUE), its last 5-days average volume was 3.27 million, which is a drop from its year-to-date volume of 7.54 million. As of the previous 9 days, the stock’s Stochastic %D was 45.54%. Additionally, its Average True Range was 0.04.
During the past 100 days, Bluebird bio Inc’s (BLUE) raw stochastic average was set at 2.79%, which indicates a significant decrease from 12.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 41.72% in the past 14 days, which was lower than the 95.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5472, while its 200-day Moving Average is $0.9701. However, in the short run, Bluebird bio Inc’s stock first resistance to watch stands at $0.4999. Second resistance stands at $0.5195. The third major resistance level sits at $0.5294. If the price goes on to break the first support level at $0.4704, it is likely to go to the next support level at $0.4605. Now, if the price goes above the second support level, the third support stands at $0.4409.
Bluebird bio Inc (NASDAQ: BLUE) Key Stats
There are currently 109,336K shares outstanding in the company with a market cap of 93.12 million. Presently, the company’s annual sales total 29,500 K according to its annual income of -211,910 K. Last quarter, the company’s sales amounted to 16,100 K and its income totaled -81,390 K.
